5 B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Aurora, CO (2026)

Q: How do I join a clinical trial in Aurora?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you.

Recruiting B-Cell Acute Lymphoblastic Leukemia Studies in Aurora

NCT06579469Recruiting

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

This study is being done to learn more about the short-term and long-term side effects of CAR-T cell therapy. Specifically, researchers want to know how often patients get infections, have delays in r...

Aurora, CO100 participantsSt. Jude Children's Research Hospital

View Study Details

NCT03509961Recruiting

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

This study will evaluate the use of non- TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD (next generation sequencing minimal resi...

Aurora, COPHASE295 participantsPediatric Transplantation & Cellular Therapy Consortium

View Study Details

NCT06559189Recruiting

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

This study will evaluate the safety and tolerability of administering a novel bispecific CD19/CD22-directed CAR T cell product (CD19x22) for the treatment of relapsed or refractory pediatric B-ALL....

Aurora, COPHASE153 participantsUniversity of Colorado, Denver

View Study Details

NCT04150497Recruiting

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

This is a first-in-human, open-label, dose escalation and expansion study of UCART22 administered intravenously to patients with relapsed or refractory B-cell acute Lymphoblastic Leukemia (B-ALL). The...

Aurora, COPHASE152 participantsCellectis S.A.

View Study Details

NCT04544592Recruiting

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

This phase I/II trial will investigate a new CD19 directed CAR-T therapy manufactured locally with the goals to expedite infusion to wider patient inclusion that includes those who were previously exc...

Aurora, COPHASE145 participantsUniversity of Colorado, Denver

View Study Details

About B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Aurora

B-cell acute lymphoblastic leukemia (B-ALL) is a fast-growing cancer of the B-type lymphocyte white blood cells. It is the most common childhood cancer but can also occur in adults. Treatment includes chemotherapy, targeted therapy, and CAR-T cell therapy.

There are currently 5 b-cell acute lymphoblastic leukemia clinical trials recruiting participants in Aurora, CO. These studies are seeking a combined 345 participants. Research is being sponsored by St. Jude Children's Research Hospital, Pediatric Transplantation & Cellular Therapy Consortium, University of Colorado, Denver and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Aurora — FAQ

Are there b-cell acute lymphoblastic leukemia clinical trials in Aurora?

Yes, there are 5 b-cell acute lymphoblastic leukemia clinical trials currently recruiting in Aurora, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Aurora?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.

Are clinical trials in Aurora free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.

What b-cell acute lymphoblastic leukemia treatments are being tested?

The 5 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for b-cell acute lymphoblastic leukemia.

Data updated October 16, 2026 from ClinicalTrials.gov